Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery

• Main Authors: R. R. C. New (Author), M. Bogus (Author), G. N. Travers (Author), U. Hahn (Author), A. Vaiceliunaite (Author), M. Burnet (Author), J. H. Wang (Author), H. Wen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

GLP-1 receptor agonists ((GLP-1 RAs) are currently receiving a lot of attention because of their impact in diabetes, weight loss and other areas. While GLP-1 RAs in injectable form are highly efficacious, further work is required to develop oral versions which can deliver these peptides efficiently...